Literature DB >> 26932159

ABC Transporters in the Development of Multidrug Resistance in Cancer Therapy.

Angelika Dlugosz, Anna Janecka1.   

Abstract

Cancer is one of the leading causes of mortality in the developed countries. The search for novel drug candidates is a priority goal for cancer therapy. However, the emergence of drug resistance reduces the effectiveness of new medications. The ATP binding cassette (ABC) family of proteins are efflux pumps that transport various structurally unrelated and potentially dangerous substances out of the cells. These transporters have evolved as a complex cellular defense system, for the recognition and removal of toxic agents entering the cells from their environment. Several of the ABC transporters are related to chemoresistance in cancer therapy, as the rapidly dividing malignant cells use them to protect themselves from medical interventions. Here we review the members of the ABC transporter families responsible for the multidrug resistance in anticancer therapy.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26932159     DOI: 10.2174/1381612822666160302103646

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  17 in total

1.  Assessment of a bifendate derivative bearing a 6,7-dihydro-dibenzo[c,e]azepine scaffold as a potential anti-metastatic agent.

Authors:  Jingying Qiu; Wang Chen; Yanfei Jiang; Jing Chen; Yinpeng Zhang; Xiaoke Gu
Journal:  Medchemcomm       Date:  2018-09-17       Impact factor: 3.597

2.  Synthesis and Anticancer Properties of New 3-Methylidene-1-sulfonyl-2,3-dihydroquinolin-4(1H)-ones.

Authors:  Agata Jaskulska; Katarzyna Gach-Janczak; Joanna Drogosz-Stachowicz; Tomasz Janecki; Anna Ewa Janecka
Journal:  Molecules       Date:  2022-06-03       Impact factor: 4.927

3.  Combined treatment with apatinib and docetaxel in A549 xenograft mice and its cellular pharmacokinetic basis.

Authors:  Si-Qi Feng; Guang-Ji Wang; Jing-Wei Zhang; Yuan Xie; Run-Bin Sun; Fei Fei; Jing-Qiu Huang; Ying Wang; Ji-Ye Aa; Fang Zhou
Journal:  Acta Pharmacol Sin       Date:  2018-05-17       Impact factor: 6.150

4.  Clerosterol from vinegar-baked radix bupleuri modifies drug transport.

Authors:  Ya Zhao; Li-Min Feng; Li-Juan Liu; Xian Zhang; Rui-Zhi Zhao
Journal:  Oncotarget       Date:  2017-03-28

5.  Expression of the cancer stem cell markers ABCG2 and OCT-4 in right-sided colon cancer predicts recurrence and poor outcomes.

Authors:  Jun Hu; Jian Li; Xin Yue; Jiacang Wang; Jianzhong Liu; Lin Sun; Dalu Kong
Journal:  Oncotarget       Date:  2017-04-25

Review 6.  Biophysical Approaches Facilitate Computational Drug Discovery for ATP-Binding Cassette Proteins.

Authors:  Steven V Molinski; Zoltán Bozóky; Surtaj H Iram; Saumel Ahmadi
Journal:  Int J Med Chem       Date:  2017-03-19

7.  Thiazole-valine peptidomimetic (TTT-28) antagonizes multidrug resistance in vitro and in vivo by selectively inhibiting the efflux activity of ABCB1.

Authors:  Yi-Jun Wang; Bhargav A Patel; Nagaraju Anreddy; Yun-Kai Zhang; Guan-Nan Zhang; Saeed Alqahtani; Satyakam Singh; Suneet Shukla; Amal Kaddoumi; Suresh V Ambudkar; Tanaji T Talele; Zhe-Sheng Chen
Journal:  Sci Rep       Date:  2017-02-09       Impact factor: 4.379

8.  Orally available tubulin inhibitor VERU-111 enhances antitumor efficacy in paclitaxel-resistant lung cancer.

Authors:  Foyez Mahmud; Shanshan Deng; Hao Chen; Duane D Miller; Wei Li
Journal:  Cancer Lett       Date:  2020-09-11       Impact factor: 9.756

Review 9.  Cancer resistance to treatment and antiresistance tools offered by multimodal multifunctional nanoparticles.

Authors:  Eudald Casals; Muriel F Gusta; Macarena Cobaleda-Siles; Ana Garcia-Sanz; Victor F Puntes
Journal:  Cancer Nanotechnol       Date:  2017-10-26

10.  Current Opinions on Chemoresistance: An Overview.

Authors:  Saba Hasan; Ruba Taha; Halima El Omri
Journal:  Bioinformation       Date:  2018-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.